Wikidata

(Q38486326)

English

A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion

scientific article published on 14 August 2011

In more languages

Statements

title
A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
author name string
Dimitar H Raev
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
Garth Dickinson
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
Noam N Butterfield
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
Brian Mangal
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
Gregory N Beatch
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
publication date
14 August 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017
page(s)
637-643
1 reference
stated in
Europe PubMed Central
PubMed ID
21841207
retrieved
3 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38486326&oldid=1761960605"